These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10995233)

  • 1. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain.
    Morrow JA; Segall ML; Lund-Katz S; Phillips MC; Knapp M; Rupp B; Weisgraber KH
    Biochemistry; 2000 Sep; 39(38):11657-66. PubMed ID: 10995233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism.
    Acharya P; Segall ML; Zaiou M; Morrow J; Weisgraber KH; Phillips MC; Lund-Katz S; Snow J
    Biochim Biophys Acta; 2002 Sep; 1584(1):9-19. PubMed ID: 12213488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of human apolipoprotein E2, E3 and E4 in solution. 2. Multidomain organization correlates with the stability of apoE structure.
    Clément-Collin V; Barbier A; Dergunov AD; Visvikis A; Siest G; Desmadril M; Takahashi M; Aggerbeck LP
    Biophys Chem; 2006 Jan; 119(2):170-85. PubMed ID: 16125836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease.
    Morrow JA; Hatters DM; Lu B; Hochtl P; Oberg KA; Rupp B; Weisgraber KH
    J Biol Chem; 2002 Dec; 277(52):50380-5. PubMed ID: 12393895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability?
    Weers PM; Narayanaswami V; Choy N; Luty R; Hicks L; Kay CM; Ryan RO
    Biophys Chem; 2003; 100(1-3):481-92. PubMed ID: 12646385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains.
    Wetterau JR; Aggerbeck LP; Rall SC; Weisgraber KH
    J Biol Chem; 1988 May; 263(13):6240-8. PubMed ID: 3360781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40).
    Aleshkov SB; Li X; Lavrentiadou SN; Zannis VI
    Biochemistry; 1999 Jul; 38(28):8918-25. PubMed ID: 10413465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution.
    Chou CY; Lin YL; Huang YC; Sheu SY; Lin TH; Tsay HJ; Chang GG; Shiao MS
    Biophys J; 2005 Jan; 88(1):455-66. PubMed ID: 15475580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4.
    Tanaka M; Vedhachalam C; Sakamoto T; Dhanasekaran P; Phillips MC; Lund-Katz S; Saito H
    Biochemistry; 2006 Apr; 45(13):4240-7. PubMed ID: 16566598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of polymorphism on the lipid interaction of human apolipoprotein E.
    Saito H; Dhanasekaran P; Baldwin F; Weisgraber KH; Phillips MC; Lund-Katz S
    J Biol Chem; 2003 Oct; 278(42):40723-9. PubMed ID: 12917433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural variation manipulates the differential oxidative susceptibility and conformational stability of apolipoprotein E isoforms.
    Su KL; Wen TH; Chou CY; Chang GG; Liu GY; Hung HC
    Proteins; 2007 Jul; 68(1):363-74. PubMed ID: 17410580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
    Bentley NM; Ladu MJ; Rajan C; Getz GS; Reardon CA
    Biochem J; 2002 Aug; 366(Pt 1):273-9. PubMed ID: 12015813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence study of domain structure and lipid interaction of human apolipoproteins E3 and E4.
    Mizuguchi C; Hata M; Dhanasekaran P; Nickel M; Okuhira K; Phillips MC; Lund-Katz S; Saito H
    Biochim Biophys Acta; 2014 Dec; 1841(12):1716-24. PubMed ID: 25281910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli.
    Morrow JA; Arnold KS; Weisgraber KH
    Protein Expr Purif; 1999 Jul; 16(2):224-30. PubMed ID: 10419818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity.
    Pham T; Kodvawala A; Hui DY
    Biochemistry; 2005 May; 44(20):7577-82. PubMed ID: 15896001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils.
    Hatters DM; Zhong N; Rutenber E; Weisgraber KH
    J Mol Biol; 2006 Sep; 361(5):932-44. PubMed ID: 16890957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of human apolipoprotein E2, E3 and E4 in solution 1. Tertiary and quaternary structure.
    Barbier A; Clément-Collin V; Dergunov AD; Visvikis A; Siest G; Aggerbeck LP
    Biophys Chem; 2006 Jan; 119(2):158-69. PubMed ID: 16139946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces.
    Futamura M; Dhanasekaran P; Handa T; Phillips MC; Lund-Katz S; Saito H
    J Biol Chem; 2005 Feb; 280(7):5414-22. PubMed ID: 15583000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific.
    Dafnis I; Argyri L; Sagnou M; Tzinia A; Tsilibary EC; Stratikos E; Chroni A
    Sci Rep; 2016 Aug; 6():30654. PubMed ID: 27476701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.